IGXBio Overview

Founded 2001
Status Private
Employees 1
Latest Deal Type Accelerator/​Inc
Investors 3

IGXBio General Information


Developer of advanced DNA immunotherapies created to target HIV infection. The company's platform GenePro, is a proprietary DNA composition that synthetically mimics the virus in order to generate an immune response that is less toxic than current AIDS drug cocktails, enabling doctors to reduce infections particularly HIV.

Contact Information

Formerly Known As
ImmunoGenetix Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 4220 Shawnee Mission Parkway
  • Suite B350
  • Fairway, KS 66205
  • United States
+1 (888) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IGXBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 01-Aug-2016 000.00 Completed Startup
4. Early Stage VC 0000 000.00 Completed Startup
3. Grant 01-Jan-2012 00000 Completed Startup
2. Accelerator/Incubator $350K Completed Startup
1. Angel (individual) 16-Feb-2006 $350K $350K Completed Startup

IGXBio Competitors (38)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
DNAtrix Venture Capital-Backed Houston, TX 00 000.00 00000000000 000.00
000000 Venture Capital-Backed Lebanon, NH 000 00000 0000000000 0 00000
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00000 00000000000 00000
00000000 000000000 Formerly VC-backed Bedford, MA 000 00000 00000000 00000
000000000 Formerly VC-backed Culver City, CA 000 00000 00000000000 00000

IGXBio Executive Team (2)

Name Title Board Seat Contact Info
James Laufenberg Executive Chairman
David Foster Ph.D President, Chief Executive Officer & Board Member

IGXBio Board Members (6)

To view IGXBio‘s full board member team, request access »
Name Representing Role Since
David Foster Ph.D Self President, Chief Executive Officer & Board Member 000 0000
David Tousley Self Board Member 000 0000
Edward Connolly Jr. Self Board Member 000 0000
Edward Stratemeier JD Self Board Member 000 0000
James Laufenberg IGXBio Executive Chairman 000 0000

IGXBio Investors (3)

To view IGXBio‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator 000 0000 000000 0
Kansas Bioscience Authority Government 000 0000 000000 0
Enterprise Center of Johnson County Not-For-Profit Venture Capital 000 0000 000000 0

Ready to get started?

Request a free trial